Compare AdaptHealth Corp (AHCO) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Kinross Gold Corporation — how do they compare? AdaptHealth Corp trades at $10.03 (market cap $1.38B), while Kinross Gold Corporation trades at $23.01 (market cap $28.53B). The key difference: Kinross Gold Corporation is far larger — about 20.7× AdaptHealth Corp's market cap, and Kinross Gold Corporation pays a 0.61% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | KGC | |
|---|---|---|
Market Cap | $1.38B | $28.53B |
Sector | Health | Basic Materials |
52-Week High | $13.38 | $38.06 |
52-Week Low | $8.68 | $15.19 |
Enterprise Value | $3.33B | $27.08B |
Dividend Yield | — | 0.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Kinross Gold (KGC) trades at $23.87, down 3.4% over 24 hours amid a bearish technical signal. The company demonstrates strong fundamentals with revenue growing from $3.5B in 2022 to $7.05B in 2025 and net income surging to $2.39B. Recent quarters show consistent earnings beats, with Q2 2026 results expected on July 29. Analyst consensus remains bullish with a $35.33 price target representing 48% upside potential.
KGC presents a compelling value opportunity with attractive valuation ratios (P/E 10.52, EV/EBITDA 5.46) and robust profitability (35.99% net margin). Key risks include gold price volatility and rising operational costs. The company's strong cash flow generation and growth projects support long-term upside, though technical indicators suggest near-term consolidation may continue.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
